Correlation Between Abcellera Biologics and Artiva Biotherapeutics,
Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and Artiva Biotherapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and Artiva Biotherapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcellera Biologics and Artiva Biotherapeutics, Common, you can compare the effects of market volatilities on Abcellera Biologics and Artiva Biotherapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of Artiva Biotherapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and Artiva Biotherapeutics,.
Diversification Opportunities for Abcellera Biologics and Artiva Biotherapeutics,
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Abcellera and Artiva is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and Artiva Biotherapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artiva Biotherapeutics, and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with Artiva Biotherapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artiva Biotherapeutics, has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and Artiva Biotherapeutics, go up and down completely randomly.
Pair Corralation between Abcellera Biologics and Artiva Biotherapeutics,
Given the investment horizon of 90 days Abcellera Biologics is expected to under-perform the Artiva Biotherapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Abcellera Biologics is 1.62 times less risky than Artiva Biotherapeutics,. The stock trades about -0.07 of its potential returns per unit of risk. The Artiva Biotherapeutics, Common is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 1,200 in Artiva Biotherapeutics, Common on September 20, 2024 and sell it today you would lose (96.00) from holding Artiva Biotherapeutics, Common or give up 8.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 43.15% |
| Values | Daily Returns |
Abcellera Biologics vs. Artiva Biotherapeutics, Common
Performance |
| Timeline |
| Abcellera Biologics |
| Artiva Biotherapeutics, |
Abcellera Biologics and Artiva Biotherapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Abcellera Biologics and Artiva Biotherapeutics,
The main advantage of trading using opposite Abcellera Biologics and Artiva Biotherapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, Artiva Biotherapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artiva Biotherapeutics, will offset losses from the drop in Artiva Biotherapeutics,'s long position.| Abcellera Biologics vs. Hepion Pharmaceuticals | Abcellera Biologics vs. Krystal Biotech | Abcellera Biologics vs. CureVac NV | Abcellera Biologics vs. Vir Biotechnology |
| Artiva Biotherapeutics, vs. Paltalk | Artiva Biotherapeutics, vs. SEI Investments | Artiva Biotherapeutics, vs. GAMCO Global Gold | Artiva Biotherapeutics, vs. Royalty Management Holding |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |